14 source-backed reviews

Read beyond the offer.

Provider terms, product details, open questions. Every review explains what the public record can—and cannot—establish.

Browse provider reviews

C↗Telehealth

CoreAge Rx

Low advertised entry prices across GLP-1 and wellness programs. The final commitment and consultation refund terms need a close read.

Read our review →
OTelehealth

OrderlyMeds

A straightforward recurring price with a much cheaper prepaid starter offer. The first three months and the fourth month are different purchases.

Read our review →
mTelehealth

Mochi Health

Medication and membership are separate. Dose-dependent starting prices need both numbers before they resemble a monthly budget.

Read our review →
HTelehealth

Henry Meds

Longer commitments create a large gap between an advertised monthly equivalent and the standard recurring program price.

Read our review →
roTelehealth

Ro

FDA-approved medication access with a separate care membership. The medicine-only number is one component of the bill.

Read our review →
A+Telehealth

AgelessRx

Several wellness routes with first-month promotions. The ongoing price and upfront billing period deserve equal attention.

Read our review →
STelehealth

Strut Health

Public injection and lozenge prices make route-specific comparison possible; the exact prescription remains a consultation decision.

Read our review →
eTelehealth

Eden

NAD+ pricing varies by vial size and commitment. The single-month plans are a clearer baseline than the largest headline discount.

Read our review →
iVTelehealth

Ivím Health

Starting GLP-1 prices include a program fee, with a program-length commitment that needs to be settled before checkout.

Read our review →
NManufacturer access

NovoCare

Wegovy pill and pen offers, where the dose, device and introductory period determine the advertised price.

Read our review →
NISkincare brand

NIOD

A lipid-rich copper-peptide balm with a stated 15 mL package. Compare the formula and quantity as well as the price.

Read our review →
VManufacturer access

Vyleesi

An FDA-approved bremelanotide product with a four-dose offer and a narrow eligibility context.

Read our review →